Litigation Details for Vanda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2020)
✉ Email this page to a colleague
Vanda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2020)
Docket | ⤷ Subscribe | Date Filed | 2020-01-21 |
Court | District Court, D. Delaware | Date Terminated | 2022-12-14 |
Cause | 35:1 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 10,449,176 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Apotex Inc.
Details for Vanda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-01-21 | 1 | Complaint | or more claims of Vanda’s U.S. Patent No. 10,449,176 (“the ’176 patent”), which, in relevant part, generally… V. THE PATENT-IN-SUIT (U.S. PATENT NO. 10,449,176) …’176 patent is attached to this Complaint as Exhibit A. 32. The ’176 patent generally…is covered by the ’176 patent, and Vanda has the right to enforce the ’176 patent and sue for infringement… 1–9 of the ’176 patent. 46. Apotex has infringed the ’176 patent under 35 U.S.C. | External link to document |
2020-01-21 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,449,176. (kmd) (Entered: 01… 21 January 2020 1:20-cv-00083 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |